Fundraising Fox
Maxwell Biosciences
Austin, US · Delaware corporation · 5 known investors
Find your way into Maxwell Biosciences
Sign up to see every warm intro you have to Maxwell Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Maxwell Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Maxwell Biosciences develops therapeutics aimed at treating infectious diseases. The company works with research and defense institutions on biodefense and antimicrobial-related work.
Founders & leadership
Investors · 5
How we know: Capital Factory's portfolio page · Not right? Tell us
How we know: Keiretsu Forum's portfolio page · Not right? Tell us
How we know: LoftyInc Capital's portfolio page · the VCSheet dataset · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$10.9M disclosed across 1 of 4 rounds · 2021–2026
▶$25MofferedJul 2023 · BiotechnologyRule 506(b)
- Joshua McClureExecutive Officer, Director, Promoter
- Kate McKinleyDirector
- Praveen TyleDirector
- Barbara R HolcombDirector
- Annelise BarronDirector
- Offering amount
- $25M
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$10.9MraisedApr 2022 · 96 investors · BiotechnologyRule 506(b)
- Praveen TyleDirector
- Annelise BarronDirector
- Theodore MoskovitzDirector
- Christopher JohnsDirector
- Joshua McClureExecutive Officer, Director
- Offering amount
- $14.8M
- Amount sold
- $10.9M
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Companies working in the same space as Maxwell Biosciences.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2021 | $256.5K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Maxwell Biosciences' Spinout SHU.ai Announces Closing of $1M Financing Roundfinance.yahoo.com · Aug 2026Frequently asked questions
- What does Maxwell Biosciences do?
- Maxwell Biosciences develops therapeutics aimed at treating infectious diseases. The company works with research and defense institutions on biodefense and antimicrobial-related work.
- Who founded Maxwell Biosciences?
- Maxwell Biosciences was founded by Joshua McClure.
- Who are Maxwell Biosciences's investors?
- Maxwell Biosciences's investors include Capital Factory, Das & Co., Keiretsu Forum, LoftyInc Capital, Transform Investments.
- How much funding has Maxwell Biosciences raised?
- Maxwell Biosciences has disclosed $10.9M raised across 1 of its 4 known rounds.
- Where is Maxwell Biosciences headquartered?
- Maxwell Biosciences is headquartered in Austin, US.